Endometrial hyperplasia: modern concepts of etiopathogenesis

Protasova A.E.; Adamyan L.V.; Sobivchak M.S.; Tsypurdeeva A.A.

doi:https://doi.org/10.17116/repro20232904175

Close metadata

Recommended articles:

Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):51-59

Unresolved problem: Chemotherapy-Induced Peripheral Neuropathy. P.A. Herzen Journal of Oncology. 2024;(5):76-81

Analysis of medical preventive structures staff resources in 2023. Russian Journal of Preventive Medicine. 2024;(10):45-51

Quality assessment of health care delivery to patients with sexually transmitted infections in dermatovenereological institutions of Moscow according to medical records analysis. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):503-509

Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):517-524

Tuberculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66

Risk factors associated with myopic maculopathy in acquired myopia. Russian Annals of Ophthalmology. 2024;(5):35-45

Rationale for the use of non-linear statistical methods in the analysis of relationships between risk factors and fatal events according to the data of long-term prospective observation in population of Russia and the United States of America. Russian Journal of Preventive Medicine. 2024;(11):34-39

Features of comorbidity pathology in young people. Russian Journal of Preventive Medicine. 2024;(11):63-69

Proton pump inhibitors: positive and negative properties. On the 45th anniversary of their discovery. Russian Journal of Preventive Medicine. 2024;(11):135-140

Abstract:

Endometrial hyperplasia is one of the topical issues of modern gynecology due to the high incidence of this pathology, as well as the risk of malignant transformation of endometrial hyperplasia into endometrial cancer. Topic of etiopathogenesis of endometrial hyperplasia remains open: the role of the hyperestrogenemia in the development of endometrial hyperplastic processes is not being studied alone, but the contribution of endometrial microbiota, epigenetics and mutational alterations as well. In this regard, there is a necessity to revise approaches to the treatment of patients with verified endometrial hyperplasia. To date, only one drug has been registered for the treatment of endometrial hyperplasia, all other medications are used «off label» according to clinical recommendations.

Keywords:

endometrial hyperplasia

etiopathogenesis

risk factors

treatment

prevention

Authors:

Protasova A.E.

Federal State Budgetary Educational Institution of Higher Education "Saint-Petersburg State University";
Federal State Budgetary Educational Institution of Higher Education "National Medical Research Center Named After V.A. Almazov» of the Ministry of Health of Russia;
AVA-PETER

ORCID: 0000-0001-7930-8048

Adamyan L.V.

Moscow State Medical and Dental University named after A.I. Evdokimov

SPIN RSCI: 9836-2713
Scopus AuthorID: 7006372422
ResearcherID: Q-1722-2018
ORCID: 0000-0002-3253-4512

Sobivchak M.S.

Federal State Budgetary Educational Institution of Higher Education "Saint-Petersburg State University"

ORCID: 0009-0007-7239-7122

Tsypurdeeva A.A.

Federal State Budgetary Educational Institution of Higher Education "Saint-Petersburg State University";
Federal State Budgetary Scientific Institution «Scientific Research Institute of Obstetrics, Gynecology and Reproductology Named After A.I. Ott» of the Ministry of Education and Science of Russia

ORCID: 0000-0002-7022-0530

Received:

23.05.2023

Accepted:

25.05.2023

Close metadata

References:

Breusenko VG, Savelyeva GM, Golova YuA, Kappusheva LM. Treatment of endometrial hyperplastic processes in peri- and postmenopausal. Akusherstvo i ginekologiya. 2009;4:19-23. (In Russ.).
Kuznetsova IV. Giperplasticheskie protsessy endometriya. M. 2009. (In Russ.).
Hannemann MM, Alexander HM, Cope NJ, Acheson N. Endometrial hyperplasia:a clinician’s review. Obstetrics Gynaecology and Reproductive Medicine. 2010;20(4):116-120. https://doi.org/10.1016/j.ogrm.2010.01.002
Tropé C, Lindahl B. Premalignant lesions of the endometrium: clinical features and management. In: Coppleson M, ed. Gynecologic Oncology. Ed. 2. New York: Churchill Livingstone; 1992:747-751.
Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, Voigt LF, Weiss NS. Incidence of endometrial hyperplasia. American Journal of Obstetrics and Gynecology. 2009 June;200(6):678.e1-678.e6. https://doi.org/10.1016/j.ajog.2009.02.032
Zheleznov BI. K probleme predraka endometriya. IV s”ezd akusherov-ginekologov RSFSR: trudy. M. 1977:188-196. (In Russ.).
Salov IA, Chesnokova NP, Kournikova VV. Modern ideas about etiological factors and risk factors for the development of endometrial hyperplastic processes. Message 1. Assessment of the epidemiological situation. Classification of endometrial hyperplastic processes. Pathomorphological characteristics, relationship with oncogynecological diseases. Uspekhi sovremennogo estestvoznaniya. 2004; 1:37-40. (In Russ.).
Sochetannye dobrokachestvennye opukholi i giperplasticheskie protsessy matki (mioma, adenomioz, giperplaziya endometriya). Adamyan LV, ed. M. 2015. (In Russ.).
Mills AM, Longacre TA. Endometrial hyperplasia. Seminars in Diagnostic Pathology. 2010;27(4):199-214. https://doi.org/10.1053/j.semdp.2010.09.002
Kondrikov NI. Strukturno-funktsional’nye osnovy giperplasticheskikh izmenenij endometriya zhenshchin: Diss. ... d-ra med. nauk. M. 1991. (In Russ.).
Frank GA, Belous TA, Sokolova NV. Morphological features of dysplastic changes of the endometrium. Arkhiv patologii. 1990;52(9):18-24. (In Russ.).
Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 2006;107(4):746-756. https://doi.org/10.1002/cncr.22044
Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL; Society of Gynecologic Oncology Clinical Practice Committee. Management of Endometrial Precancers. Obstetrics and Gynecology. 2012;120(5):1160-1175. https://doi.org/10.1097/aog.0b013e31826bb121
Lokuhetty D, White VA, Watanabe RL. Internal Agency for Research on Cancer (IARC). Female Genital Tumours. WHO Classification of Tumours Editorial Board. 5th ed. 2020.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs. WHO Classification of Tumours. 4th ed. 2014.
Endometroid intraepithelial neoplasia (EIN). Atypical endometrial hyperplasia. Pathology Outlines. 2018. Accessed June 30, 2023. https://www.pathologyoutlines.com/topic/uterusein.html.
Management of Endometrial Hyperplasia. RCOG/BSGE Green-top Guideline N 67. 2016. Accessed June 30, 2023. https://www.rcog.org.uk
Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. International Journal of Gynaecology and Obstetrics. 2018;143(3):393-408. https://doi.org/10.1002/ijgo.12666
Giperplaziya endometriya. Klinicheskie rekomendatsii. Odobreno Nauchno-prakticheskim Sovetom Minzdrava RF. 2021. Accessed June 30, 2023. (In Russ.).
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C; ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Annals of Oncology. 2016;27(1):16-41. https://doi.org/10.1093/annonc/mdv484
NCCN Guidelines Version 1.2021. Uterine Neoplasms. Accessed June 30, 2023. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473
Sharma A, Lastra RR. Endometrial Hyperplasia / Endometrioid Intraepithelial Neoplasia (EIN). PathologyOutlines. 2020. Accessed June 30, 2023. https://www.pathologyoutlines.com/topic/uterusendometrialhyperplasiageneral.html
Wise MR, Jordan V, Lagas A, Showell M, Wong N, Lensen S, Farquhar CM. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. American Journal of Obstetrics and Gynecology. 2016;214(6):689.e1-689.e17. https://doi.org/10.1016/j.ajog.2016.01.175
Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncology. 2002;3(9):565-574. https://doi.org/10.1016/s1470-2045(02)00849-5
Bobrowska K, Kamin´ski P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, Durlik M, Paczek L. High rate of endometrial hyperplasia in renal transplanted women. Transplantation Proceedings. 2006; 38(1):177-179. https://doi.org/10.1016/j.transproceed.2005.12.007
Kubyshkin AV, Aliev LL, Fomochkina II, Kovalenko YP, Litvinova SV, Filonenko TG, Lomakin NV, Kubyshkin VA, Karapetian OV. Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia. Inflammation Research. 2016;65(10):785-794. https://doi.org/10.1007/s00011-016-0960-z
Alper ECD, Coşkun ADE, Vural F. Comparison of nonspecific inflammatory markers in endometrial cancer and hyperplasia. Revista da Associacao Medica Brasileira. 2021;67(7):966-970. https://doi.org/10.1590/1806-9282.20210318
Walther-Antonio MR, Chen J, Multinu F, Hokenstad A, Distad TJ, Cheek EH, Keeney GL, Creedon DJ, Nelson H, Mariani A. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Medicine 2016;8:122. https://doi.org/10.1186/s13073-016-0368-y
Hereditary Cancer Syndromes and Risk Assessment No. 634. ACOG committee opinion. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. 2017;125:1538-1543.
Antonsen SL, Ulrich L, Høgdall C. Patients with atypical hyperplasia of theendometrium should be treated in oncological centers. Gynecologic Oncology. 2012;125(1):124-128. https://doi.org/10.1016/j.ygyno.2011.12.436

Kumar P, Magon N. Hormones in pregnancy. Nigerian Medical Journal. 2012;53(4):179-183. https://doi.org/10.4103/0300-1652.107549

Napso T, Yong HEJ, Lopez-Tello J and Sferruzzi-Perri AN. The Role of Placental Hormones in Mediating Maternal Adaptations to Support Pregnancy and Lactation. Frontiers in Physiology. 2018;9:1091. https://doi.org/10.3389/fphys.2018.01091

Van Hagen IM, Roos-Hesselink JW. Aorta pathology and pregnancy. Best Practice and Research. Clinical Obstetrics and Gynaecology. 2014;28(4):537-550.

Warnes CA. Pregnancy and Delivery in Women with Congenital Heart Disease. Circulation Journal. 2015;(79):1416-1421. https://doi.org/10.1253/circj.CJ-15-0572

Wald RM, Silversides CK, Kingdom J, Toi A, Lau CS, Mason J, Colman JM, Sermer M, Siu SC. Maternal cardiac output and fetal doppler predict adverse neonatal outcomes in pregnant women with heart disease. Journal of the American Heart Association. 2015;4(11):e002414. https://doi.org/10.1161/JAHA.115.002414

Verlohren S, Melchiorre K, Khalil A, Thilaganathan.B. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound in Obstetrics and Gynecology. 2014;44(3):293-298. https://doi.org/10.1002/uog.13310

Thalmann M, Sodeck G.H, Domanovits H, Grassberger M, Loewe C, Michael Grimm, Czerny M. Acute type A aortic dissection and pregnancy: a population-based study. European Journal of Cardio-Thoracic Surgery. 2011;39(Issue 6):159-e163. https://doi.org/10.1016/j.ejcts.2010.12.070

Friel LA. Troubles Cardiaques Pendant la Grossesse University of Texas Health Medical School at Houston. McGovern Medical School;2017.

Niwa K, Perloff JK, Bhuta SM, Laks H, Drinkwater DC, Child JS, Miner PD. Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses. Circulation. 2001;103(3):393-400. https://doi.org/10.1161/01.cir.103.3.393

Oliver JM, Gallego P, Gonzalez A, Aroca A, Bret M, Mesa JM. Risk factors for aortic complications in adults with coarctation of the aorta. Journal of the American College of Cardiology. 2004;44(8):1641-1647. https://doi.org/10.1016/j.jacc.2004.07.037

Krywko DM, King KC. Aortocaval Compression Syndrome. StatPearls Publishing. Aug 08, 2022.

Ohlson L. Effects of the pregnant uterus on the abdominal aorta and its branches. Acta Radiologica: Diagnosis.1978;19(2):369-376. https://doi.org/10.1177/028418517801900212

Saeki N, Taguchi S, Kawamoto M. Successful management ofa patient with Marfan syndrome complicated with acute aorticdissection using landiolol during cesarean section. Journal of Anesthesia. 2010;24(2):277-279. https://doi.org/10.1007/s00540-009-0859-8

Yuan Shi-Min. Bicuspid aortic valve in pregnancy. Taiwanese Journal of Obstetrics and Gynecology. 2014;53(4):476-480. https://doi.org/10.1016/j.tjog.2013.06.018

Kamel H, Roman MJ, Pitcher A, Devereux RB. Pregnancy and the Risk of Aortic Dissection or Rupture. A Cohort-Crossover Analysis. Circulation. 2016;134(7):527-533. https://doi.org/10.1161/CIRCULATIONAHA.116.021594

Yuan S-M. Aortic Dissection During Pregnancy: A Difficult Clinical Scenario. Clinical Cardiology. 2013;36(10):576-584. https://doi.org/10.1002/clc.22165

Wanga S, Silversides C, Dore A, de Waard V, Mulder B. Pregnancy and thoracic aortic disease: managing the risks. Canadian Journal of Cardiology. 2016;32(1):78-85. https://doi.org/10.1016/j.cjca.2015.09.003

Osol G, Ko NL, Mandalà M. Plasticity of the maternal vasculature during pregnancy. Annual Review of Physiology. 2019;81:89-111. https://doi.org/10.1146/annurev-physiol-020518-114435

Cherpak BV, Davydova YV, Kravchenko VI, Yaschuk NS, Siromakha SO, Lazoryshynets VV. Management of percutaneous treatment of aorta coarctation diagnosed during pregnancy. Journal of Medicine and Life. 2022;15(2):208-213. https://doi.org/10.25122/jml-2021-0363

Connolly HM, Huston J 3rd, Brown RD Jr, Warnes CA, Ammash NM, Tajik AJ. Intracranial aneurysms in patients with coarctation of the aorta: a prospective magnetic resonance angiographic study of 100 patients. Mayo Clinic Proceedings. 2003;78(12):1491-1499. https://doi.org/10.4065/78.12.1491

Singh PK, Marzo A, Staicu C, William MG, Wilkinson I, Lawford PV, Rufenacht DA, Bijlenga P, Frangi AF, Hose R, Patel UJ, Coley SC. The Effects of Aortic Coarctation on Cerebral Hemodynamics and its Importance in the Etiopathogenesis of Intracranial Aneurysms. Journal of Vascular and Interventional Neurology. 2010;3(1):17-30.

Dias MS, Sekhar LN. Intracranial haemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990;27(6):855-865. https://doi.org/10.1097/00006123-199012000-00001

Mehrotra M, Mehrotra A, Nair A, Srivastava A, Sahu RN, Pradhan M, Kuma R. Intracranial hemorrhage from giant aneurysm in pregnancy: A rare association. Asian Journal of Neurosurgery. 2017; 12(1):142-144. https://doi.org/10.4103/1793-5482.145553

Miller HJ, Hinkley CM: Berry aneurysms in pregnancy: a 10 year report. Southern Medical Journal. 1970;63(3):279. https://doi.org/10.1097/00007611-197003000-00007

Kim YW, Neal D, Hoh BL. Cerebral Aneurysms in Pregnancy and Delivery: Pregnancy and Delivery Do Not Increase the Risk of Aneurysm Rupture. Neurosurgery. 2013;72(Issue 2):143-150. https://doi.org/10.1227/NEU.0b013e3182796af9

Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 ACC/AHA guidelines on adult congenital heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139(14):637-697. https://doi.org/10.1161/CIR.0000000000000602

Ntiloudi D, Zegkos T, Bazmpani MA, Parcharidou D, Panagiotidis T, Hadjimiltiades S, Karvounis H, Giannakoulas G. Pregnancy outcome in women with congenital heart disease: A single-center experience. Hellenic Journal of Cardiology. 2018;59(3):155-159. https://doi.org/10.1016/j.hjc.2017.08.008

Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, Mulder BJ, Oudijk MA, Roos-Hesselink JW, Cornette J, van Dijk AP, Spaanderman ME, Drenthen W, van Veldhuisen DJ; ZAHARA II investigators. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation. 2013;128(23): 2478-2487. https://doi.org/10.1161/CIRCULATIONAHA.113.002810

Siegmund AS, Kampman MAM, Bilardo CM, Balci A, van Dijk APJ, Oudijk MA, Mulder BJM, Roos-Hesselink JW, Sieswerda GT, Koenen SV, Sollie-Szarynska KM, Ebels T, van Veldhuisen DJ, Pieper PG; ZAHARA investigators. Pregnancy in women with corrected aortic coarctation: uteroplacental doppler flow and pregnancy outcome. Journal of Cardiology. 2017;249:145-150. https://doi.org/10.1016/j.ijcard.2017.09.167

Avanzas P, García-Fernández M.A, Quiles J, Datino T, Moreno M. Pseudoaneurysm complicating aortic coarctation in a pregnant woman. International Journal of Cardiology. 2004;9(1):157-158. https://doi.org/10.1016/j.ijcard.2003.06.037

Mravyan SR, Petrukhin VA, Pronina VP, Vishnyakova MV, Abramenko AS, Khapiy NH, Lysenko SN. The course of pregnancy and delivery of patients who underwent surgery for aortic coarctation. Rossijskij vestnik akushera-ginekologa. 2014;14(6):49-54. (In Russ.).

Irtyuga OB, Mgdesyan KO, Moiseeva OM. Features of pregnancy and childbirth management in patients with aortic and aortic valve pathology. Rossijskij kardiologicheskij zhurnal. 2017;2:80-86. (In Russ.).

Butalia S, Audibert F, Côté AM. Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Canadian Journal of Cardiology. 2018;(34):526-531. https://doi.org/10.1016/j.cjca.2018.02.021

Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation. 2014;130:703-714. https://doi.org/10.1161/CIRCULATIONAHA.113.003664

Moore LG, Shriver M, Bemis L, Hickler B, Wilson M, Brutsaert T, Parra E, Vargas E. Maternal adaptation to high-altitude pregnancy: an experiment of nature — a review. Placenta. 2004;25(Suppl A): 60-71. https://doi.org/10.1016/j.placenta.2004.01.008

Ladouceur M, Benoit L, Radojevic J, Basquin A, Dauphin C, Hascoet S, Moceri P, Bredy C, Iserin L, Gouton M, Nizard J. Pregnancy Outcomes in Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease. Heart. 2017;103(4): 287-292. https://doi.org/10.1136/heartjnl-2016-310003

Knight M, Nair M, Tuffnell D, Shakespeare J, Kenyon S, Kurinczuk JJ, eds; on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care—Lessons Learned to Inform Maternity Care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2013–15. Oxford: National Perinatal Epidemiology Unit. University of Oxford, 2017

Ramlakhan KP, Tobler D, Greutmann M, Schwerzmann M, Baris L, Yetman AT, Nihoyannopoulos P, Manga P, Boersma E, Maggioni AP, Johnson MR, Hall R, Roos-Hesselink JW; ROPAC investigators group. On behalf of the ROPAC investigators group. Pregnancy outcomes in women with aortic coarctation. Heart. 2021;107(4): 290-298. https://doi.org/10.1136/heartjnl-2020-317513

WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. Geneva World Health Organization; 2011.

Ananth CV, Keyes KM, Wapner RJ. Pre-Eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564. https://doi.org/10.1136/bmj.f6564

Boerma T, Ronsmans C, Melesse DY, Barros AJD, Barros FC, Juan L, Moller AB, Say L, Hosseinpoor AR, Yi M, de Lyra Rabello Neto D, Temmerman M. Global epidemiology of use of and disparities in caesarean sections. Lancet. 2018;392:1341-1348. https://doi.org/10.1016/S0140-6736(18)31928-7